317 related articles for article (PubMed ID: 16905219)
1. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination.
Borges O; Cordeiro-da-Silva A; Romeijn SG; Amidi M; de Sousa A; Borchard G; Junginger HE
J Control Release; 2006 Sep; 114(3):348-58. PubMed ID: 16905219
[TBL] [Abstract][Full Text] [Related]
2. Preparation of coated nanoparticles for a new mucosal vaccine delivery system.
Borges O; Borchard G; Verhoef JC; de Sousa A; Junginger HE
Int J Pharm; 2005 Aug; 299(1-2):155-66. PubMed ID: 15998569
[TBL] [Abstract][Full Text] [Related]
3. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
[TBL] [Abstract][Full Text] [Related]
4. In vitro uptake of lysozyme-loaded liposomes coated with chitosan biopolymer as model immunoadjuvants.
Madrigal-Carballo S; Vila AO; Sibaja M; Reed JD; Molina F
J Liposome Res; 2010 Mar; 20(1):1-8. PubMed ID: 19514859
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-based nanoparticles as a hepatitis B antigen delivery system.
Lebre F; Bento D; Jesus S; Borges O
Methods Enzymol; 2012; 509():127-42. PubMed ID: 22568904
[TBL] [Abstract][Full Text] [Related]
6. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.
van der Lubben IM; Verhoef JC; van Aelst AC; Borchard G; Junginger HE
Biomaterials; 2001 Apr; 22(7):687-94. PubMed ID: 11246962
[TBL] [Abstract][Full Text] [Related]
7. Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa.
Simonoska Crcarevska M; Glavas Dodov M; Goracinova K
Eur J Pharm Biopharm; 2008 Mar; 68(3):565-78. PubMed ID: 17651952
[TBL] [Abstract][Full Text] [Related]
8. Microparticulate polyelectrolyte complexes for gentamicin transport across intestinal epithelia.
Iannuccelli V; Montanari M; Bertelli D; Pellati F; Coppi G
Drug Deliv; 2011 Jan; 18(1):26-37. PubMed ID: 20726809
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
Amidi M; Romeijn SG; Borchard G; Junginger HE; Hennink WE; Jiskoot W
J Control Release; 2006 Mar; 111(1-2):107-16. PubMed ID: 16380189
[TBL] [Abstract][Full Text] [Related]
10. In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry.
Van Der Lubben IM; Konings FA; Borchard G; Verhoef JC; Junginger HE
J Drug Target; 2001; 9(1):39-47. PubMed ID: 11378522
[TBL] [Abstract][Full Text] [Related]
11. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system.
Coppi G; Iannuccelli V
Int J Pharm; 2009 Feb; 367(1-2):127-32. PubMed ID: 18940240
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-reinforced alginate microspheres obtained through the emulsification/internal gelation technique.
Ribeiro AJ; Silva C; Ferreira D; Veiga F
Eur J Pharm Sci; 2005 May; 25(1):31-40. PubMed ID: 15854798
[TBL] [Abstract][Full Text] [Related]
13. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
Borges O; Cordeiro-da-Silva A; Tavares J; Santarém N; de Sousa A; Borchard G; Junginger HE
Eur J Pharm Biopharm; 2008 Jun; 69(2):405-16. PubMed ID: 18364251
[TBL] [Abstract][Full Text] [Related]
14. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles.
Salman HH; Gamazo C; Agüeros M; Irache JM
Vaccine; 2007 Nov; 25(48):8123-32. PubMed ID: 18029067
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
Wittaya-areekul S; Kruenate J; Prahsarn C
Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.
Borges O; Tavares J; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
Eur J Pharm Sci; 2007 Dec; 32(4-5):278-90. PubMed ID: 17884394
[TBL] [Abstract][Full Text] [Related]
17. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme.
Rawat M; Singh D; Saraf S; Saraf S
Drug Dev Ind Pharm; 2008 Feb; 34(2):181-8. PubMed ID: 18302037
[TBL] [Abstract][Full Text] [Related]
18. Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice.
Shakweh M; Besnard M; Nicolas V; Fattal E
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):1-13. PubMed ID: 16005619
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
Slütter B; Plapied L; Fievez V; Sande MA; des Rieux A; Schneider YJ; Van Riet E; Jiskoot W; Préat V
J Control Release; 2009 Sep; 138(2):113-21. PubMed ID: 19445980
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique.
Yoo MK; Kang SK; Choi JH; Park IK; Na HS; Lee HC; Kim EB; Lee NK; Nah JW; Choi YJ; Cho CS
Biomaterials; 2010 Oct; 31(30):7738-47. PubMed ID: 20656343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
